Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy
Article in Pharmaceutics (April 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (October 2023)
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
Article in Pharmaceuticals (May 2023)